Riskpilot← Back to searchSign inGet full accessMRSA AS
ASActiveOrg 912184161Skåregata 112, 5527 HaugesundGeneral medical practice activities · NACE 8621Est. 20130 employees
Revenue 2025
NOK 0
EBITDA margin
—
-61% vs 2024
Equity ratio
5.7%
Financial strength
Net profit 2025
NOK -197K
-3% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -31K | -61% |
| Net profit | NOK -197K | -3% |
| Total assets | NOK 4M | -4% |
| Equity | NOK 229K | -46% |
| Employees | 0 | — |
Legal name
MRSA AS
Org number
912184161
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
10. juli 2013
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og nestleder hver for seg. Styrets leder og ett styremedlem i fellesskap.
Company purpose
Investering i aksjer og verdipapirer, investering i og utvikling av fast eiendom samt det som står i forbindelse med dette.
Address
Skåregata 112, 5527 Haugesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −2 | −17 | −17 | −21 | −17 | −23 | −16 | −16 | −0 | −16 | −18 | −19 | −31 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 | −17 | −17 | −21 | −17 | −23 | −16 | −16 | −0 | −16 | −18 | −19 | −31 |
| Net financials | 0 | 0 | 0 | 0 | 399 | 369 | −70 | −73 | 197 | 61 | −149 | −172 | −166 |
| Profit before tax | −1 | −17 | −17 | −21 | 382 | 346 | −86 | −89 | 197 | 44 | −167 | −192 | −197 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 | −17 | −17 | −21 | 382 | 346 | −86 | −89 | 197 | 44 | −167 | −192 | −197 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 042 | 4 042 | 4 030 | 4 030 | 4 030 | 4 030 | 4 030 | 4 030 | 4 057 | 4 039 | 4 207 | 4 217 | 4 030 |
| Equity | 45 | 27 | 10 | −10 | 371 | 718 | 632 | 543 | 740 | 785 | 618 | 426 | 229 |
| Long-term debt | 4 000 | 4 000 | 4 000 | 4 000 | 3 611 | 3 242 | 3 312 | 3 384 | 3 214 | 3 151 | 3 485 | 3 670 | 3 661 |
| Short-term debt | −3 | 14 | 20 | 41 | 48 | 71 | 87 | 103 | 103 | 103 | 104 | 122 | 140 |
| Total debt | 3 997 | 4 014 | 4 020 | 4 041 | 3 659 | 3 313 | 3 399 | 3 487 | 3 317 | 3 255 | 3 589 | 3 791 | 3 801 |
EBITDA margin
-3130400.0%
This company
15.8%
Market median
-19812758% vs market
20132025
Equity ratio
5.7%
This company
38.2%
Market median
-85% vs market
20132025
Return on equity
-86.3%
This company
18.4%
Market median
-569% vs market
20132025
Net profit margin
-19730500.0%
This company
8.1%
Market median
-243586520% vs market
20132025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132025
Debt / equity
16.63×
This company
0.62×
Market median
-2582% vs market
20132025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2013 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2013 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MRSA AS 
HAUGESUND MEDISINSKE ALLMENNLEGER ASBoard members of MRSA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monika Wiese | Board of Directors | 0 companies |
| Eirik Røthing Simonsen | Board of Directors | 0 companies |
| Sidney Charleton Felecian | Chairman | 0 companies |
| Anne Kvalheim | Board of Directors | 0 companies |